SBRASabra Health Care REIT, Inc.(SBRA)Stock Analysis

AI analysis on 2,800+ stocks →
Real EstateNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1492298SBRA stock profile & AI dashboard →

13F Pro Quality Score

73.5/100

Rank #193 of 2,879 stocksTOP 10%

View Real Estate peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

83.3/100

Profitability

95.0/100

Balance Sheet

58.5/100

Earnings Quality

95.8/100

Free Cash Flow

96.3/100

Institutional Flow

52.1/100

Revenue Scale

32.4/100

Dilution Risk

47.5/100

SBRA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Sabra Health Care REIT, Inc. (SBRA), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores SBRA at 73.5/100 on a 32-signal composite quality model, placing it at rank #193 of 2,879 stocks — the top 10% of the AI-ranked universe. SBRA scores in the top quartile across free cash flow (96.3), earnings quality (95.8), profitability (95.0). Areas of concern include revenue scale (32.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Sabra Health Care REIT, Inc. reports quarterly revenue of $221.8M, net income of $40.9M, an operating margin of 17.8%. Top institutional holders of SBRA by reported 13-F value include BlackRock,, PRINCIPAL FINANCIAL GROUP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. SBRA trades on the Nasdaq exchange and files with the SEC under CIK 1492298. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SBRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sabra Health Care REIT, Inc. directly from SEC EDGAR. Sabra Health Care REIT, Inc.'s 13F Pro composite quality score has ranged between 8 and 85 since 2021, currently 73.5 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about Sabra Health Care REIT, Inc.

Quirks, history, and lore behind SBRA — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. real estate investment trust · mid-cap · listed on Nasdaq · headquartered in California.
  • 2
    The Numbers
    Owns a portfolio of roughly 400 properties across the U.S. and Canada, generating annual revenues in the hundreds of millions of dollars.
  • 3
    The History
    Formed in 2010 as a spinoff from a larger healthcare REIT, it was built from the start to focus exclusively on senior housing and care facilities.
  • 4
    The Secret
    Its tenants aren't retailers or office workers — they're skilled nursing operators and senior living providers, making demographic aging its ultimate tailwind.
  • 5
    The Lore
    The company's very name nods to its mission: "Sabra" is a Hebrew word for a native-born Israeli, evoking resilience — fitting for a REIT betting on America's aging population.
  • 6
    The Giveaway
    Ticker SBRA, based in Irvine, and entirely focused on skilled nursing facilities and senior housing — this REIT is one of the largest pure-play healthcare landlords on the market.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$221.8M

Net Income

Q1 2026

$40.9M

Free Cash Flow

Q1 2026

$98.4M

Operating Margin

Q1 2026

17.8%

ROIC

Q1 2026

0.7%

D/E Ratio

Q1 2026

0.96

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+10.2% YoY
$774.6MFY 2025
FY22 $624.8MFY23 $647.5MFY24 $703.2MFY25 $774.6M

Net Income

+22.8% YoY
$155.6MFY 2025
FY22 $-77.6MFY23 $13.8MFY24 $126.7MFY25 $155.6M

EPS (Diluted)

+18.5% YoY
$0.64FY 2025
FY22 $-0.34FY23 $0.06FY24 $0.54FY25 $0.64

Total Assets

+3.6% YoY
$5.49BFY 2025
FY22 $5.75BFY23 $5.39BFY24 $5.30BFY25 $5.49B

Total Debt

+4.6% YoY
$2.53BFY 2025
FY22 $2.51BFY23 $2.41BFY24 $2.42BFY25 $2.53B

Op. Cash Flow

+12.3% YoY
$348.6MFY 2025
FY22 $315.7MFY23 $300.6MFY24 $310.5MFY25 $348.6M

Get alerted when SBRA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Sabra Health Care REIT, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of SBRA

Put SBRA on your watchlist

Track score changes the day Sabra Health Care REIT, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is SBRA a good stock to buy?

13F Pro's AI-powered analysis of Sabra Health Care REIT, Inc. (SBRA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SBRA are available on the SBRA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SBRA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SBRA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Sabra Health Care REIT, Inc.'s investment landscape.